Vol 3, No 1 (2010)
Program edukacyjny "Zagadnienia współczesnej nefrologii" - Nefro Club
Published online: 2010-03-31
Diagnostyka schorzeń nerek i układu moczowego u dzieci i młodzieży - wybrane zagadnienia
Forum Nefrologiczne 2010;3(1):51-56.
Abstract
Nowoczesna diagnostyka chorób nerek i układu moczowego
u dzieci obejmuje szeroki zakres badań
czynnościowych, obrazowych, molekularnych i genetycznych.
Służą one nie tylko wykrywaniu określonych
chorób, ale także monitorowaniu ich leczenia,
przewidywaniu zagrożenia rozwojem przewlekłej
choroby nerek i jej wielonarządowych odległych skutków. Postęp w tej dziedzinie i stałe poszukiwanie
bardziej czułych, swoistych, a zarazem mniej
inwazyjnych technik diagnostycznych przyczyniają
się do podwyższenia standardu opieki nefrologicznej
u dzieci.
Keywords: diagnostykaobrazowaniebadania czynnościowebadania molekularnebadania genetyczneocena uszkodzenia naczyń
References
- Westwood ME, Whiting PF, Cooper J, et al. Further investigation of confirmed urinary tract infection (UTI) in children under five years: a systematic review. BMC Pediatr. 2005; 5(1): 1–10.
- Lee MD, Lin CC, Huang FY, et al. Screening young children with a first febrile urinary tract infection for high-grade vesicoureteral reflux with renal ultrasound scanning and technetium-99m-labeled dimercaptosuccinic acid scanning. J Pediatr. 2009; 154(6): 797–802.
- Levart TK, Kljucevsek D, Kenig A, et al. Sensitivity of ultrasonography in detecting renal parenchymal defects: 6 years' follow-up. Pediatr Nephrol. 2009; 24(6): 1193–1197.
- Leyendecker JR, Clingan MJ. Magnetic resonance urography update--are we there yet? Semin Ultrasound CT MR. 2009; 30(4): 246–257.
- Abdulsamea S, Anderson P, Biassoni L, et al. Renovascular hypertension in children. Lancet. 2008; 371(9622): 1453–1463.
- Reusz GS, Kis E, Cseprekál O, et al. Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension. Pediatr Nephrol. 2010; 25(2): 185–189.
- Clemente A, Macchi V, Porzionato A, et al. CTA and 2D-3D post-processing: radiological signs of fibromuscular dysplasia of renal artery. Surg Radiol Anat. 2009; 31(1): 25–29.
- Huang Y, Duncan AA, McKusick MA, et al. Renal artery intervention in pediatric and adolescent patients: a 20-year experience. Vasc Endovascular Surg. 2007; 41(6): 490–499.
- Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009; 24(4): 707–719.
- Litwin M, Wühl E, Jourdan C, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol. 2005; 16(5): 1494–1500.
- Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens. 2004; 13(6): 661–665.
- Zouvani I, Aristodemou S, Hadjisavvas A, et al. Incidence of thin basement membrane nephropathy in 990 consecutive renal biopsies examined with electron microscopy. Ultrastruct Pathol. 2008; 32(6): 221–226.
- Naesens M, Li Li, Ying L, et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol. 2009; 20(8): 1839–1851.
- Piotto GHM, Moraes MCM, Malheiros DM, et al. Percutaneous ultrasound-guided renal biopsy in children - safety, efficacy, indications and renal pathology findings: 14-year Brazilian university hospital experience. Clin Nephrol. 2008; 69(6): 417–424.
- Woźniewicz B, Wyszyńska T, Tysarowska A. Badanie biopsyjne nerki. In: Sieniawska M, Wyszyńska T. ed. Nefrologia dziecięca. OIN Polfa, Warszawa 2003: 137–140.
- Grenda R, Wühl E, Litwin M, et al. ESCAPE Trial group. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial. Nephrol Dial Transplant. 2007; 22(12): 3487–3494.
- Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K. Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol. 2009; 24(4): 753–759.
- Taha MA, Shokeir AA, Osman HG, et al. Pelvi-ureteric junction obstruction in children: the role of urinary transforming growth factor-beta and epidermal growth factor. BJU Int. 2007; 99(4): 899–903.
- Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol. 2006; 2(3): 157–168.
- Wasilewska AM, Zoch-Zwierz WM. Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors. Pediatr Nephrol. 2004; 19(12): 1349–1353.
- Hinkes BG, Mucha B, Vlangos CN, et al. on behalf of Arbeitsgemainschaft für Paediatrische Nephrologie Study Group: Nephrotic syndrome in the first year of life: two third of cases are caused by mutations of genes NPHS1, NPHS2, WT1 and LAMB2. Pediatrics. 2007; 119: e907–e919.
- Schwaderer P, Knüppel T, Konrad M, et al. Clinical course and NPHS2 analysis in patients with late steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2008; 23(2): 251–256.
- Gbadegesin R, Hinkes B, Vlangos C, et al. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2007; 22(4): 509–513.
- Weber S, Gribouval O, Esquivel EL, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 2004; 66(2): 571–579.
- Woudenberg-Vrenken TE, Bindels RJM, Hoenderop JGJ. The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol. 2009; 5(8): 441–449.
- Walz G. Slit or pore? A mutation of the ion channel TRPC6 causes FSGS. Nephrology Dialysis Transplantation. 2005; 20(9): 1777–1779.
- Winn MP, Daskalakis N, Spurney RF, et al. Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications? J Am Soc Nephrol. 2006; 17(2): 378–387.
- Peten E, Pirson Y, Cosyns JP, et al. Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation. 1991; 52(5): 823–826.
- Fischbach BV, Trout KL, Lewis J, et al. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005; 116(4): 984–988.
- McTaggart SJ, Algar E, Chow CW, et al. Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol. 2001; 16(4): 335–339.
- Huff V. Genotype/phenotype correlations in Wilms' tumor. Med Pediatr Oncol. 1996; 27(5): 408–414.
- Pope JC, Brock JW, Adams MC, et al. How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol. 1999; 10(9): 2018–2028.
- Weber S, Moriniere V, Knüppel T, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol. 2006; 17(10): 2864–2870.
- Loirat C, Niaudet P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol. 2003; 18(11): 1095–1101.
- Loirat C, Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant. 2008; 12(6): 619–629.
- Kavanagh D, Richards A, Fremeaux-Bacchi V, et al. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2007; 2(3): 591–596.
- Chatelet V, Frémeaux-Bacchi V, Lobbedez T, et al. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am J Transplant. 2009; 9(11): 2644–2645.
- Woudenberg-Vrenken TE, Bindels RJM, Hoenderop JGJ. The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol. 2009; 5(8): 441–449.
- Zawadzki J. Kwasice cewkowe. Kamica. In: Grenda R. ed. Postępy nefrologii dziecięcej. PZWL, Warszawa 2002: 11–24.
- Kuczera M, Swatowski A. Rozpoznawanie i leczenie kamicy nerkowej. In: Rutkowski B, Czekalski S. ed. Rozpoznawanie i leczenie chorób nerek. Termedia, Poznań 2008: 108–116.
